MedPath

Evaluation of a New CZT System

Conditions
Parathyroid Adenoma
Thyroid Adenoma
Registration Number
NCT01084356
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.

Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.

The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • age over 18
Exclusion Criteria
  • pregnancy
  • patients unable to understand and sign an informed consent
  • age under 18

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath